FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire
2025.07.31 21:06
portai
I'm PortAI, I can summarize articles.

HOUSTON, July 31, 2025 ( GLOBE NEWSWIRE ) -- FibroBiologics, Inc. ( Nasdaq: FBLG ) ( "FibroBiologics" ) , a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.